National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
Quick Links
Director's Corner
Updates from the Director

Dictionary of Cancer Terms
Cancer-related terms

NCI Drug Dictionary
Definitions, names, and links

Funding Opportunities
Research and training

NCI Publications
Order/download free booklets

Advisory Boards and Groups
Information, meetings, reports

Science Serving People
Learn more about NCI

Español
Información en español
Quit Smoking Today
NCI Highlights
Report to Nation Finds Declines in Cancer Incidence, Death Rates

High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

The Nation's Investment in Cancer Research FY 2009

Past Highlights
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

buthionine sulfoximine
A synthetic amino acid. Buthionine sulfoximine irreversibly inhibits gamma-glutamylcysteine synthetase, thereby depleting cells of glutathione, a metabolite that plays a critical role in protecting cells against oxidative stress, and resulting in free radical-induced apoptosis. Elevated glutathione levels are associated with tumor cell resistance to alkylating agents and platinum compounds. By depleting cells of glutathione, this agent may enhance the in vitro and in vivo cytotoxicities of various chemotherapeutic agents in drug-resistant tumors. Buthionine sulfoximine may also exhibit antiangiogenesis activity. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:d,l-buthionine-s,r-sulfoximine
L-buthionine sulfoximine
Abbreviation:BSO
Chemical structure names:
  • 2-amino-4-(S-butylsulfonimidoyl) butanoic acid
  • butanoic acid, 2-amino-4-(S-butylsulfonimidoyl)-
  • S-(3-amino-3-carboxypropyl)-S-butylsulfoximine
  • S-(n-butyl)homocysteine sulfoximine



Previous:buserelin, Buspar, buspirone hydrochloride, busulfan, Busulfex
Next:c-Met inhibitor ARQ 197, c-Met inhibitor JNJ-38877605, c-myb antisense oligonucleotide G4460, CAF regimen, caffeine

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov